The following is a summary of “Introducing Neoadjuvant Immunotherapy for Colorectal Cancer: Advancing the Frontier,” ...

Researchers have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy.

Bowel cancer is the fourth most common cancer in the UK, and the second most common cause of cancer death. The disease falls ...

Researchers at the Francis Crick Institute and Barts Cancer Institute, Queen Mary University of London, have shown that the amount of a protein called CD74 can indicate which people with bowel cancer ...

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, ...

CAFs, cancer-associated fibroblasts; CAR-T, chimeric antigen receptor-T; CRC, colorectal cancer ... may help guide the identification of candidates for this immunotherapy approach. In conclusion, ...

Women are now being diagnosed with cancer more often than men in certain age groups, according to a new report from the ...

Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors.

Data were summarized with the search of 'colorectal' and 'antibody' as of August 2012 at ClinicalTrials.gov [202]. EGFR: EGF receptor; mAb: Monoclonal antibody; VEGFR: VEGF receptor. The authors ...

Plasmodium Immunotherapy is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Colorectal Cancer.

evaluating the potential of investigational AlloStim ® in combination with avelumab in patients who are suffering from ...

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial Colorectal cancer (CRC) remains a major global ...